Roles of Novel Cannabinoid Chemicals O-1602 and Cannabidiol in DSS-induced Mouse Colitis

FENG Ya-jing,LI Yong-yu,LIN Xu-hong,LI Kun,YU Liang-ying,CAO Ming-hua,XU Jing
DOI: https://doi.org/10.3969/j.issn.1000-4718.2012.08.019
2012-01-01
Abstract:AIM:To investigate the roles of O-1602 and cannabidiol(CBD) in dextran sulfate sodium(DSS)-induced mouse colitis.METHODS: The model of colitis was induced in C57BL/6 mice by drinking water containing 4% DSS for 7 days.The model mice were treated with O-1602(5 mg/kg),CBD(1 mg/kg) or SB203580 [an inhibitor of p38 mitogen-activated protein kinase(MAPK) at dose of 5 μmol/kg].A colitis scoring system was used to evaluate the colon local lesion,and the systemic inflammatory responses were observed by detecting the plasma levels of tumor necrosis factor α(TNF-α),interleukin 6(IL-6) and cytokine-induced neutrophil chemoattractant 1(CINC-1),and the activity of myeloperoxidase(MPO) in the lung tissues.The expression of G protein-coupled receptor 55(GPR55) was detected by the method of immunohistochemistry.The expression of p38 and phosphorylated p38(p-p38) in colon tissues was determined by Western blotting.RESULTS: O-1602 and CBD improved the pathological changes in the mice with DSS-induced colitis and decreased the plasma levels of TNF-α,IL-6 and CINC-1,and the activity of MPO in the lung tissues(P0.05).Lower expression of p-p38 was observed after treatment with O-1602,CBD and SB203580(P0.05).The expression of GPR55 was mainly in the submucosa of mouse colon tissues.CONCLUSION: O-1602 and CBD show protective effect on the mice with experimental colitis,and the anti-inflammatory roles of O-1602 and CBD are related to the inhibition of p38 MAPK.The expression level of GPR55 in the submucosa of mouse colon tissue is low.
What problem does this paper attempt to address?